PAFAH1B1 and cholangiocarcinoma: Expression of miR-380 is abnormal in cholangiocarcinoma, and its upregulation reduces the expression of MMP-2/p-AKT through targeted regulation of LIS1, thereby inhibiting the proliferation, S-phase arrest and invasiveness of cholangiocarcinoma cells.